CME Group Inc. Logo

CME Group Inc.

0HR2.L

(0.0)
Stock Price

216,64 USD

3.17% ROA

11.73% ROE

23.55x PER

Market Cap.

70.990.028.000,00 USD

12.17% DER

4.89% Yield

57.89% NPM

CME Group Inc. Stock Analysis

CME Group Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

CME Group Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

6 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

7 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

CME Group Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

CME Group Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

CME Group Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

CME Group Inc. Revenue
Year Revenue Growth
2012 2.914.600.000
2013 2.931.200.000 0.57%
2014 3.112.500.000 5.82%
2015 3.326.800.000 6.44%
2016 3.595.200.000 7.47%
2017 3.644.700.000 1.36%
2018 4.309.400.000 15.42%
2019 4.868.000.000 11.47%
2020 4.883.600.000 0.32%
2021 4.564.200.000 -7%
2022 5.008.800.000 8.88%
2023 5.341.200.000 6.22%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

CME Group Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 97.600.000 100%
2017 101.600.000 3.94%
2018 117.200.000 13.31%
2019 201.500.000 41.84%
2020 198.500.000 -1.51%
2021 192.600.000 -3.06%
2022 188.600.000 -2.12%
2023 222.400.000 15.2%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

CME Group Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 300.200.000
2013 317.100.000 5.33%
2014 333.400.000 4.89%
2015 338.900.000 1.62%
2016 377.800.000 10.3%
2017 365.500.000 -3.37%
2018 453.900.000 19.48%
2019 547.800.000 17.14%
2020 634.700.000 13.69%
2021 581.200.000 -9.21%
2022 646.000.000 10.03%
2023 669.200.000 3.47%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

CME Group Inc. EBITDA
Year EBITDA Growth
2012 1.945.100.000
2013 1.891.700.000 -2.82%
2014 2.017.000.000 6.21%
2015 2.228.600.000 9.49%
2016 2.448.100.000 8.97%
2017 2.509.700.000 2.45%
2018 2.929.900.000 14.34%
2019 3.129.400.000 6.38%
2020 3.137.800.000 0.27%
2021 2.874.800.000 -9.15%
2022 3.365.300.000 14.58%
2023 3.634.000.000 7.39%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

CME Group Inc. Gross Profit
Year Gross Profit Growth
2012 2.914.600.000
2013 2.931.200.000 0.57%
2014 3.112.500.000 5.82%
2015 3.326.800.000 6.44%
2016 3.595.200.000 7.47%
2017 3.644.700.000 1.36%
2018 4.309.400.000 15.42%
2019 4.868.000.000 11.47%
2020 4.883.600.000 0.32%
2021 4.564.200.000 -7%
2022 5.008.800.000 8.88%
2023 5.341.200.000 6.22%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

CME Group Inc. Net Profit
Year Net Profit Growth
2012 896.300.000
2013 976.800.000 8.24%
2014 1.127.100.000 13.34%
2015 1.247.000.000 9.62%
2016 1.534.100.000 18.71%
2017 4.063.400.000 62.25%
2018 1.962.200.000 -107.08%
2019 2.116.500.000 7.29%
2020 2.105.199.999 -0.54%
2021 2.617.100.000 19.56%
2022 2.657.200.000 1.51%
2023 2.963.200.000 10.33%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

CME Group Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 3
2013 3 0%
2014 3 33.33%
2015 4 0%
2016 5 25%
2017 12 63.64%
2018 6 -120%
2019 6 0%
2020 6 0%
2021 7 28.57%
2022 7 0%
2023 8 12.5%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

CME Group Inc. Free Cashflow
Year Free Cashflow Growth
2012 1.077.900.000
2013 1.154.900.000 6.67%
2014 1.150.700.000 -0.36%
2015 1.418.300.000 18.87%
2016 1.640.200.000 13.53%
2017 1.669.200.000 1.74%
2018 2.324.100.000 28.18%
2019 2.427.200.000 4.25%
2020 2.518.100.000 3.61%
2021 2.275.200.000 -10.68%
2022 2.966.300.000 23.3%
2023 836.800.000 -254.48%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

CME Group Inc. Operating Cashflow
Year Operating Cashflow Growth
2012 1.219.700.000
2013 1.280.500.000 4.75%
2014 1.291.400.000 0.84%
2015 1.532.500.000 15.73%
2016 1.732.000.000 11.52%
2017 1.751.100.000 1.09%
2018 2.440.800.000 28.26%
2019 2.672.800.000 8.68%
2020 2.715.600.000 1.58%
2021 2.402.400.000 -13.04%
2022 3.056.000.000 21.39%
2023 856.700.000 -256.72%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

CME Group Inc. Capital Expenditure
Year Capital Expenditure Growth
2012 141.800.000
2013 125.600.000 -12.9%
2014 140.700.000 10.73%
2015 114.200.000 -23.2%
2016 91.800.000 -24.4%
2017 81.900.000 -12.09%
2018 116.700.000 29.82%
2019 245.600.000 52.48%
2020 197.500.000 -24.35%
2021 127.200.000 -55.27%
2022 89.700.000 -41.81%
2023 19.900.000 -350.75%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

CME Group Inc. Equity
Year Equity Growth
2012 21.505.700.000
2013 21.160.500.000 -1.63%
2014 20.923.500.000 -1.13%
2015 20.551.800.000 -1.81%
2016 20.340.700.000 -1.04%
2017 22.411.800.000 9.24%
2018 25.965.300.000 13.69%
2019 26.159.299.999 0.74%
2020 26.351.500.000 0.73%
2021 27.399.300.000 3.82%
2022 26.878.700.000 -1.94%
2023 28.151.600.000 4.52%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

CME Group Inc. Assets
Year Assets Growth
2012 38.863.200.000
2013 54.277.800.000 28.4%
2014 72.241.500.000 24.87%
2015 67.359.399.999 -7.25%
2016 69.369.400.000 2.9%
2017 75.791.200.000 8.47%
2018 77.475.700.000 2.17%
2019 75.215.300.000 -3.01%
2020 124.659.600.000 39.66%
2021 196.780.300.000 36.65%
2022 174.175.700.000 -12.98%
2023 125.598.200.000 -38.68%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

CME Group Inc. Liabilities
Year Liabilities Growth
2012 17.357.500.000
2013 33.117.300.000 47.59%
2014 51.318.000.000 35.47%
2015 46.807.600.000 -9.64%
2016 49.028.700.000 4.53%
2017 53.379.400.000 8.15%
2018 51.510.400.000 -3.63%
2019 49.056.000.000 -5%
2020 98.308.100.000 50.1%
2021 169.381.000.000 41.96%
2022 147.297.000.000 -14.99%
2023 97.446.600.000 -51.16%

CME Group Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
14.84
Net Income per Share
8.37
Price to Earning Ratio
23.55x
Price To Sales Ratio
13.3x
POCF Ratio
20.91
PFCF Ratio
21.44
Price to Book Ratio
2.52
EV to Sales
12.87
EV Over EBITDA
19.16
EV to Operating CashFlow
20.26
EV to FreeCashFlow
20.75
Earnings Yield
0.04
FreeCashFlow Yield
0.05
Market Cap
70,99 Bil.
Enterprise Value
68,69 Bil.
Graham Number
121.45
Graham NetNet
-263.13

Income Statement Metrics

Net Income per Share
8.37
Income Quality
1.11
ROE
0.11
Return On Assets
0.02
Return On Capital Employed
0.03
Net Income per EBT
0.78
EBT Per Ebit
1.21
Ebit per Revenue
0.62
Effective Tax Rate
0.22

Margins

Sales, General, & Administrative to Revenue
0.13
Research & Developement to Revenue
0.04
Stock Based Compensation to Revenue
0.02
Gross Profit Margin
0.81
Operating Profit Margin
0.62
Pretax Profit Margin
0.74
Net Profit Margin
0.58

Dividends

Dividend Yield
0.05
Dividend Yield %
4.89
Payout Ratio
1.06
Dividend Per Share
9.65

Operating Metrics

Operating Cashflow per Share
9.43
Free CashFlow per Share
9.21
Capex to Operating CashFlow
-0.02
Capex to Revenue
-0.01
Capex to Depreciation
-0.22
Return on Invested Capital
0.08
Return on Tangible Assets
0.03
Days Sales Outstanding
38.18
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
9.56
Payables Turnover
0
Inventory Turnover
0
Capex per Share
-0.22

Balance Sheet

Cash per Share
6,69
Book Value per Share
78,28
Tangible Book Value per Share
-7.22
Shareholders Equity per Share
78.28
Interest Debt per Share
9.52
Debt to Equity
0.12
Debt to Assets
0.03
Net Debt to EBITDA
-0.64
Current Ratio
1.03
Tangible Asset Value
-2,60 Bil.
Net Current Asset Value
-6,67 Bil.
Invested Capital
0.12
Working Capital
2,90 Bil.
Intangibles to Total Assets
0.24
Average Receivables
0,58 Bil.
Average Payables
0,05 Bil.
Average Inventory
0
Debt to Market Cap
0.05

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

CME Group Inc. Dividends
Year Dividends Growth
2018 1
2023 3 66.67%

CME Group Inc. Profile

About CME Group Inc.

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.

CEO
Mr. Terrence A. Duffy
Employee
3.565
Address
20 South Wacker Drive
Chicago, 60606

CME Group Inc. Executives & BODs

CME Group Inc. Executives & BODs
# Name Age
1 Ms. Hilda Harris Piell
Senior MD & Chief Human Resources Officer
70
2 Mr. Jack Tobin
MD & Chief Accounting Officer
70
3 Mr. Jonathan L. Marcus
Senior MD & General Counsel
70
4 Mr. John C. Peschier
Managing Director of Investor Relations
70
5 Mr. Kendal Vroman
Chief Transformation Officer
70
6 Ms. Anita Liskey
Senior Managing Director of Corporate Marketing & Communications
70
7 Mr. Terrence A. Duffy
Chairman & Chief Executive Officer
70
8 Ms. Julie Holzrichter
Senior MD & Chief Operating Officer
70
9 Mr. Sunil Cutinho
Chief Information Officer
70
10 Ms. Lynne Fitzpatrick
Chief Financial Officer
70

CME Group Inc. Competitors

Humana Inc. Logo
Humana Inc.

0J6Z.L

(1.8)
Moody's Corporation Logo
Moody's Corporation

0K36.L

(0.0)
Stryker Corporation Logo
Stryker Corporation

0R2S.L

(0.0)
Danaher Corporation Logo
Danaher Corporation

0R2B.L

(0.0)